National Bank of Canada
LEGN icon

National Bank of Canada’s Legend Biotech LEGN Stock Holding History

National Bank of Canada’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-210,100
Closed -$7.13M – 3131
2025
Q1 		$7.13M Buy
+210,100
New +$7.53M 0.01% 814
2022
Q3 		– Sell
-25,200
Closed -$1.39M – 2805
2022
Q2 		$1.39M Buy
+25,200
New +$1.06M 0.01% 906
2022
Q1 		– Sell
-71,300
Closed -$3.32M – 2952
2021
Q4 		$3.32M Buy
+71,300
New +$3.62M 0.01% 676

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

National Bank of Canada's LEGN Position: Q2 2025 in Review

National Bank of Canada sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 210,100 shares — an estimated $7.13M sold.

National Bank of Canada first reported a position in LEGN in Q4 2021 and held it in 3 quarters. The position peaked at $7.13M in Q1 2025. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • National Bank of Canada reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • National Bank of Canada sold 210,100 Legend Biotech shares in Q2 2025, an estimated $7.13M.
  • National Bank of Canada first reported a position in Legend Biotech in Q4 2021 and held it in 3 quarters.
  • National Bank of Canada's Legend Biotech position peaked at $7.13M in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.